The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Showers this evening with heavier and more persistent rain arriving overnight. A wet start tomorrow but improving during the afternoon.
A mother from Neath has told how her teenage son collapsed and was left unconscious for five hours after taking a so-called legal high.
Two brothers from Cardiff are campaigning for their cousin's murder to be re-investigated, 76 years after she died.